Frontlight ResearchEarly access
Active, not recruitingNo phase
Fermented Garlic Lettuce Powder and Cognitive Function in Adults With Mild Cognitive Impairment
Key facts
- Who runs it
- Pusan National University Yangsan Hospital
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 60 people enrolled
- Started
- 19 Sept 2025
- Ended
- 21 Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Garlic Lettuce Fermented Powder
- Placebo
- Record updated
- 12 January 2026
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults aged 19 years or older with K-MoCA scores between 16 and 23
- Individuals with sufficient vision and hearing to participate in the study without difficulty
- Participants who are currently taking medications or receiving treatments that may affect cognition and are able to maintain the same dosage and regimen throughout the study period
- Individuals who voluntarily agree to participate in the study and provide written informed consent
Who cannot take part
- Individuals who have undergone vascular-related surgery within the past 6 months or gastrointestinal surgery that may affect absorption of the study product (excluding simple appendectomy or hernia repair)
- Individuals with a clinically significant history of hypersensitivity to medications or dietary supplements
- Individuals with a history of alcohol or drug abuse
- Individuals unable to communicate effectively
- Individuals who have participated in more than two dietary supplement studies or clinical trials within the current year, or within the past 6 months
- Individuals deemed unable to participate safely or effectively in the study by the investigator
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
"This study aims to investigate the cognitive and psychological changes in adults with mild cognitive impairment (K-MoCA scores between 16 and 23) following daily consumption of fermented garlic lettuce powder for 2 months
The 2 groups in the trial
- Fermented Garlic Lettuce PowderTreatment being tested
Participants receive fermented garlic lettuce powder, administered orally as three tablets per day for 2 months (total of 180 tablets).
Treatment: Garlic Lettuce Fermented Powder
- Placebo TabletPlacebo, for comparison
Participants take 1 placebo tablet daily for 2 months, totaling 60 tablets
Treatment: Placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Fermented Garlic Lettuce Powder on Cognitive Function in Adults With Mild Cognitive Impairment: An Investigator-Initiated, Randomized, Assessor-Blinded, Parallel-Group, Controlled, Single-Center Study
- Record updated
- 12 January 2026